Combination therapy with topotecan, paclitaxel, and bevacizumab improves progression-free survival in recurrent small cell neuroendocrine carcinoma of the cervix

M. Frumovitz, M. F. Munsell, J. K. Burzawa, L. A. Byers, P. Ramalingam, J. Brown, R. L. Coleman

Research output: Contribution to journal › Article › peer-review

50 Scopus citations

Fingerprint

Dive into the research topics of 'Combination therapy with topotecan, paclitaxel, and bevacizumab improves progression-free survival in recurrent small cell neuroendocrine carcinoma of the cervix'. Together they form a unique fingerprint.

Medicine & Life Sciences